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Abstract
The classical concept of ATP-demand control of energy metabolism in skeletal muscle has to be modified on the basis of
studies showing the influence of additional controlling parameters (reducing equivalent supply, oxygen availability, proton
leak, diffusion restrictions and the creatine kinase system) and on the basis of applications of metabolic control analysis
showing very clearly multistep control. This concept of multistep control allows to quantify the individual influence of any
parameter on mitochondrial oxidative phosphorylation and is extremely helpful to analyze the metabolic consequences of
enzyme deficiencies in skeletal muscle occurring in mitochondrial myopathies. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Skeletal muscle is known to be a tissue of high
energy demand. It consists mainly of slow twitch
(‘type 1’) and fast twitch (‘type 2a and 2b’) ¢bers.
The type 1 and type 2a ¢bers are mitochondria-rich
and rely in their ATP supply mainly on oxidative
phosphorylation, while type 2b ¢bers are mitochon-
dria-poor and have a very e¡ective glycolytic ATP
production. The ¢ber type composition of individual
muscles is muscle speci¢c and highly variable upon
electrical stimulation [1]. Therefore, skeletal muscle
has to be considered as a heterogeneous tissue and
the large di¡erences in enzyme composition of the
individual myo¢bers may create problems in the de-
tailed description of the metabolism in the tissue in
its entirety. Nevertheless, the high ATP turnover
which is to about 50^70% utilized by actomyosin
ATPase, the big cell size and the rather simple me-
tabolism o¡er advantages for the study of basic prin-
ciples of control of oxidative phosphorylation. More-
over, the interest to the control of mitochondrial
oxidative phosphorylation in skeletal muscle has
been considerably increased since the discovery of a
group of heterogeneous myopathies which are caused
by mutations of the mitochondrial DNA (for review
see [2]). However, control in its biochemical context
is a vague term and needs a precise de¢nition. This
de¢nition is given in a neutral sense by Kacser and
Burns [3] who de¢ned that control implies a quanti-
tative relationship between components of a system.
Since control of oxidative phosphorylation is dis-
cussed in this review, the system has to be de¢ned.
A simpli¢ed scheme which illustrates the main com-
ponents of the system and the corresponding £uxes
of reducing equivalents (in three boxes from left), of
protons (fourth box from left) and phosphate (¢fth
box from left) is outlined in Fig. 1.
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2. Classical view of control of oxidative phosphoryla-
tion
In earlier work with isolated mitochondria it was
demonstrated that the rate of oxygen consumption
was greatly increased by the addition of an external
ADP-regenerating system (hexokinase/glucose, [4]).
The rate of oxidative phosphorylation was therefore
postulated to be controlled by ADP [5] or by the
extramitochondrial phosphorylation potential [6]. In
later work the adenine nucleotide carrier which con-
nects the matrix and extramitochondrial adenine nu-
cleotide pools was suggested as the rate limiting step
in respiration [7]. Since this carrier catalyzes the ex-
change of ATP43 for ADP33 [8], the respiration of
isolated mitochondria was considered to be con-
trolled by the extramitochondrial ATP/ADP ratio
[9,10]. In line with these results obtained with iso-
lated mitochondria reconstituted with external ATP
consumers, calculations on the basis of in vivo 31P
nuclear magnetic resonance (NMR) measurements
revealed that the ATP turnover rate in contracting
skeletal muscle increases about 30-fold while the
ATP/ADP ratio decreases about ¢ve times [11].
This was interpreted in terms of nearly exclusive con-
trol of ATP £ux by energy demand, e.g. actomyosin
ATPase [12]. Variations of the phosphate concentra-
tion in the physiological range (1^10 mM) have been
shown to have only little in£uence on control of oxi-
dative phosphorylation in skeletal muscle [13].
3. Reinterpretation of OXPHOS control in broader
context
That this rather simpli¢ed description of control of
oxidative phosphorylation in skeletal muscle is in-
complete has been noted by many investigators. It
is visible from Fig. 1 that additional factors in addi-
tion to the ATP utilization by actomyosin ATPase
have to be considered for a more detailed description
of control of oxidative phosphorylation in skeletal
muscle. At least the following ¢ve additional process-
es have to be taken into consideration: supply of
reducing equivalents, (ii) oxygen availability, (iii)
the proton leak, (iv) di¡usion restrictions and (v)
the creatine kinase system.
(i) A main factor which is assumed to modulate
the supply of reducing equivalent is the free Ca2
concentration which was observed to in£uence
the activities of dehydrogenases [14]. This mech-
anism was used to explain the discrepancies of
tissue high energy phosphate concentrations de-
termined by 31P NMR spectroscopy, NADH/
NAD ratios and metabolic £ux rates observed
in perfused heart muscle preparations [15,16].
Really, also in skeletal muscle in some experi-
ments during transition from resting to working
state, an increase in NADH/NAD was observed
[17,18]. However, in contrast to the extensive evi-
dence reported for the heart muscle [15,16], these
results were not con¢rmed by other groups either
in intact skeletal muscle [19,20] nor in isolated
preparations like saponin-permeabilized skeletal
muscle ¢bers [21,22].
(ii) For most tissues it has been suggested that the
control of electron £ux by oxygen concentration
appears to be minimal since the Km of respiration
for oxygen in cells and isolated mitochondria
seems to be less than 1 WM [23,24] and the di¡u-
sion of oxygen in most tissues is rapid enough to
prevent the formation of steep oxygen gradients
[25]. However, in skeletal muscle there are well
known aerobic/anaerobic transitions during exer-
cise which in turn should in£uence the control of
oxidative phosphorylation. The maximal oxygen
consumption of skeletal muscle in vivo was re-
ported to be proportional to oxygen supply with-
out attainable saturation [26] and maximal aero-
Fig. 1. Schematic representation of the pathway structure of
oxidative phosphorylation in skeletal muscle. The arrows indi-
cate £uxes of reducing equivalents, protons or phosphate which
are coupled (with the exception of the proton leak £ux). SH2 ^
mitochondrial substrates; vWH ^ electrochemical proton gra-
dient; ATP/ADPmit ^ ATP/ADP ratio in the mitochondrial in-
termembrane space; ATP/ADPcon ^ ATP/ADP ratio at the site
of ATP consumers (mainly actomyosin ATPase).
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bic muscle activity was postulated to be limited
by cardiac output and oxygen supply to the
muscle [27]. This concept was further improved
by Hogan et al. [28] who demonstrated that the
regulation of energy metabolism in oxidative skel-
etal muscle was dependent on oxygen tension (cf.
also [29]). Due to the large size of individual ¢-
bers in skeletal muscle, rather steep oxygen gra-
dients can be formed [30]. The controlling in£u-
ence of low oxygen tension, which is realized in
the cytochrome c oxidase reaction, is also shown
in experiments with saponin-permeabilized muscle
¢bers [31].
(iii) In experiments with isolated perfused rat
hindquarter, the proton leak accounts for approx-
imately one-half of the oxygen consumption of
the resting muscle [32]. This result points to a
considerable thermogenesis of the resting skeletal
muscle. Upon stimulation of muscle this control-
ling e¡ect of the proton leak decreases but was
estimated to contribute at doubled oxygen con-
sumption of the perfused rat hindquarter prepa-
ration still to about 34% of respiration rate [33].
These results were obtained by direct measure-
ments of rates of oxygen consumption and mito-
chondrial membrane potential in perfused rat
hindquarter preparations in which approximately
15% of the containing muscle tissue is stimulated.
However, upon maximal stimulation the oxygen
consumption of the working muscle increases
more than 10-fold [34], and under these circum-
stances the contribution of proton leak is very
likely to be much lower (cf. [35]).
(iv) In many 31P NMR studies describing the con-
trol of oxidative phosphorylation in muscle, cel-
lular compartmentation and related di¡usion con-
trol of an important reaction has not been taken
into consideration so far. In these experiments,
the ADP concentration is calculated assuming
equilibrium of the creatine kinase reaction which
is however very unlikely to be valid at high £ux
rates [36]. The in£uence of di¡usion limitations
for ADP through the porin pore of the mitochon-
drial outer membrane is demonstrated in compe-
tition experiments with reconstituted systems con-
sisting of isolated mitochondria an di¡erent
external ATP consumers [37]. Under in vivo con-
ditions, the tight interaction of mitochondria with
the cytoskeleton [38,39] and the mitochondrial
heterogeneity within individual muscle ¢bers [40]
a¡ecting the ADP di¡usion could also be impor-
tant. The high complexity of skeletal muscle, al-
ready present at the level of a single muscle ¢ber,
can be visualized if the distribution of mitochon-
dria is studied by confocal microscopy of £avo-
protein auto£uorescence [40]. This £uorescence
originates almost exclusive from the mitochon-
drial £avoprotein K-lipoamide dehydrogenase
[41]. One confocal plane across a saponin-per-
meabilized single human muscle ¢ber (and its re-
constructed cross section) in its endogenous oxi-
dized state is shown in Fig. 2 (left two images). It
Fig. 2. Confocal planes and reconstructed cross sections of £avoprotein auto£uorescence of a single human skeletal muscle ¢ber. Ex-
perimental conditions as described in [40]. To the substrate free incubation (left two images) 1 mM octanoylcarnitine and 5 mM ma-
late were added (right two images). Fiber diameter 375 Wm.
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can be seen that the auto£uorescence signal is in
the subsarcolemmal region substantially brighter.
That led in the reconstituted cross section to the
higher £uorescence in the border region of the
¢ber. The addition of mitochondrial substrates
(octanoylcarnitine+malate) to the ¢ber quenched
partially the £avoprotein £uorescence due to the
reduction of the £avin moiety of K-lipoamide de-
hydrogenase and a¡ected the subsarcolemmal
fraction of mitochondria to a greater extent (the
£uorescence is in both images now nearly even
distributed, Fig. 2 right two images), indicating
metabolic heterogeneity (cf. discussion in [40]).
(v) In skeletal muscle tissue, the creatine kinase
system seems to be an essential constituent of the
energy metabolism, partly to overcome the in (iv)
mentioned di¡usion restrictions for ADP across
the mitochondrial outer membrane [37,42]. The
presence of this shuttle system leads in the pres-
ence of this di¡usion barrier to a dramatic de-
crease of the Km of oxidative phosphorylation
for ADP and at high £ux rates to a displacement
of the creatine kinase equilibrium [43]. This can
cause very £at plots when [ADP] or [ATP]/[ADP]
is plotted against the respiration rate (cf. discus-
sion by Wyss et al. in [36]). In contrast to heart
muscle, in skeletal muscle, mainly due to the high
activity of myo¢brillar creatine kinase and the
lower mitochondrial content, several experimental
data and theoretical estimations testify however
against any signi¢cant displacement of creatine
kinase from equilibrium under in vivo conditions
[44^46]. Therefore, the large changes in ATP
turnover (30-fold) at only about 4-fold changes
in [ATP]/[ADP] determined by 31P NMR in intact
skeletal muscle [11] which seem to be in apparent
contradiction to ¢ndings with isolated mitochon-
dria, can be explained by a parallel activation of
ATP demand and ATP production (cf. discussion
in [11,47]).
4. Application of metabolic control analysis
A completely new view on control of oxidative
phosphorylation emerged from the application of
metabolic control analysis developed independently
by Kacser and Burns [48] and Heinrich and Rapo-
port [49]. So called £ux control coe⁄cients (initially
named ‘control strength’) were de¢ned which allowed
a quanti¢cation of control of each individual en-
zyme. The ¢rst applications of this theory to an oxi-
dative phosphorylation system consisting of isolated
rat liver mitochondria reconstituted with a glucose/
hexokinase ATP consumer were performed by Groen
et al. [50] and Gellerich et al. [51]. As main result,
both groups reported that the control of £ux is
shared among the individual components of the OX-
PHOS system and the values of £ux control coe⁄-
cients depend as well on £ux rates of oxidative phos-
phorylation as on the detailed composition of the
reconstituted system.
4.1. Enzyme-based approach (‘bottom up’ approach)
The basic principle of this method for experimen-
tal determination of £ux control coe⁄cients consists
in inhibitor titration experiments performed with
speci¢c, either irreversible or reversible non-compet-
itive, inhibitors. If these inhibitors are available it is
possible to perform an analysis of a metabolic system
starting from individual enzymes (‘bottom up’ ap-
proach).
As shown by Groen et al. [50] for irreversible in-
hibitors, the following equation for the £ux control
coe⁄cient Ci of the enzyme i can be applied:
Ci  3dJ=J=dI=Imax 1
where J is the respiration £ux, dJ is the decrement of
respiration £ux caused by the increment of inhibitor
addition dI and Imax is the maximal amount of in-
hibitor. For reversible non-competitive inhibitors this
equation has to be modi¢ed to
Ci  3dJ=J=dI=Kd 2
where Kd is the dissociation constant of the inhibitor.
Using these equations, £ux control coe⁄cients of
individual enzymes of respiratory chain can be deter-
mined experimentally. Applying this concept to iso-
lated muscle mitochondria in comparison to liver
mitochondria, important di¡erences were detected.
In the active state of glutamate oxidizing rat skeletal
muscle mitochondria control is shared more or less
uniformly between many steps [52,53], while in rat
liver mitochondria most of the control is localized at
the ATP/ADP carrier [50,51]. This phenomenon is
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most probably related to di¡erences in the detailed
protein composition of the mitochondria from the
di¡erent tissues [52]. The tissue speci¢city of distri-
bution of £ux control of oxidative phosphorylation is
extensively discussed recently by Mazat and cowork-
ers [54]. They noted that the active state respiration
of skeletal muscle and heart mitochondria is con-
trolled essentially at the level of respiratory chain
while liver, kidney and brain mitochondria were ob-
served to be controlled mainly on the phosphoryla-
tion level [54].
One problem of the ‘bottom up’ approach is the
relatively large experimental error of the graphical
method for determination of £ux control coe⁄cients
[50]. To overcome this di⁄culty a curve ¢tting pro-
cedure which analyzes the entire titration curve has
been emphasized [55]. This approach has also been
applied to describe the control of oxidative phos-
phorylation in the more complex system of calci-
um-activated saponin-permeabilized rat soleus ¢bers
[13]. By the addition of 2 WM free calcium, the oxy-
gen consumption rate of ¢bers could be stimulated
approximately 4-fold reaching approximately 80% of
active state respiration. In this in vitro system, the
control of oxidative phosphorylation was observed
to be split almost equally between mitochondrial en-
zymes and the ATP consumers (mainly the actomyo-
sin ATPase).
4.2. Subsystem-based approach (‘top down’
approach)
The main disadvantage of the enzyme-based meth-
od for the description of a complex metabolic system
is the di⁄culty of experimental determination of £ux
control coe⁄cients for all enzymes of the pathway
since speci¢c inhibitors with well known kinetic
properties are often missing. Therefore, it is often
advantageous to dissect the complex metabolic path-
way structure into subsystems for which the metabol-
ic control analysis can be performed. This subsystem
approach was suggested theoretically by Bohnensack
[56] and applied for control analysis of oxidative
phosphorylation in bull spermatozoa [57] and of
the L-oxidation pathway in rat liver mitochondria
[58]. The theoretical basis of this approach is the
connectivity theorem [48,49] which connects the
£ux control coe⁄cients of two enzymes Ca and Cb
(or two complex enzyme systems) having a common
intermediate i with their elasticity coe⁄cients in re-
spect to this common intermediate Oai and O
b
i .
Ca  O ai  Cb  O bi  0 3
and the summation property of £ux control coe⁄-
cients:
Ca  Cb  1 4
The elasticity coe⁄cients can be assessed experi-
mentally and for the determination of £ux control
coe⁄cients the system of the two equations has to
be solved yielding:
Ca  3O bi =O ai3O bi  5
and
Cb  O ai =O ai3O bi  6
The detailed application and development of this
approach to study complex metabolic networks,
named later ‘top down’ approach, was performed
by Brand and coworkers [35,59,60]. It was applied
to perform a metabolic control analysis of a large
number of metabolic systems [32,61^63]. Applying
this method, the considerable contribution of the
proton leak (having a £ux control coe⁄cient of
0.38) to the control of respiration of resting skeletal
muscle was shown [32,33]. This ¢nding indicates that
the mitochondrial proton leak signi¢cantly contrib-
utes to the basic metabolic rate and has to be con-
sidered as an important thermoregulatory mecha-
nism. Problems with the application of the top
down approach may arise if the precise structure of
the metabolic pathway is not known or the common
intermediate metabolite cannot be assessed. How-
ever, the general agreement of results obtained with
the classical enzyme-based ‘bottom up’ approach and
the ‘top down’ approach for the very simple pathway
of oxidative phosphorylation in submitochondrial
particles was experimentally shown by Moreno-San-
chez et al. [64].
5. Implications to mitochondrial myopathies and
threshold concept
Based on the interpretation of the sigmoidal
shaped inhibitor titration curves of enzymes of mito-
chondrial respiratory chain having low £ux control
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coe⁄cients, a threshold concept describing the meta-
bolic e¡ect of enzyme de¢ciencies has been developed
[65,66]. This concept predicts from the sigmoidal
shaped inhibitor titration curves of respiratory chain
complexes with speci¢c inhibitors the occurrence of
thresholds if the activity or the expression of these
enzyme is a¡ected by mutations of the mitochondrial
DNA observed in mitochondrial myopathies. In gen-
eral the £ux control coe⁄cients of these enzyme com-
plexes are rather low, causing therefore high thresh-
old values [66]. As an example, for cytochrome c
oxidase in rat skeletal muscle mitochondria oxidizing
pyruvate and malate, threshold values of about 80%
have been determined [53,66]. However, these results
are speci¢c to the respiratory substrates used (cf. also
detailed discussion in [67]). To illustrate this problem
of dependency of metabolic thresholds on the de-
tailed experimental system, a typical cyanide titration
curve of ADP-stimulated respiration of succinate+
glutamate+malate oxidizing rat skeletal muscle mito-
chondria is shown in Fig. 3A. In analogy to titra-
tions with the substrates pyruvate+malate (cf. [66]),
this titration curve is also sigmoidal shaped. If under
identical conditions the cytochrome c oxidase reac-
tion rate, using the substrates TMPD+ascorbate, is
titrated with cyanide then the hyperbolic curve
shown in Fig. 3B is obtained. As introduced by Le-
tellier et al. [66] from the combination of both titra-
tion curves, a so called threshold plot shown in Fig.
4 can be constructed. Surprisingly, in this plot a clear
metabolic threshold is nearly missing. In line with
earlier data with mice skeletal muscle ¢bers [70,69],
a low threshold value of approximately 30% and a
low excess capacity (1.4-fold) of cytochrome c oxi-
dase can be calculated (according to [68,69]) for rat
skeletal muscle mitochondria. This seems to be in
clear contrast to the mentioned very similar experi-
ments in [66,67] with the substrate combination pyr-
uvate+malate which reported a metabolic threshold
of cytochrome c oxidase of about 70^80%. This ap-
parent discrepancy is most likely related to the large
di¡erences in maximal oxygen consumption rates
with the individual substrate combinations used since
the following rates can be determined for rat skel-
etal muscle mitochondria: pyruvate+malate, 188 þ 61
Fig. 3. Cyanide titrations of maximal oxygen consumption of
isolated rat skeletal muscle mitochondria oxidizing succinate+
glutamate+malate (A) or TMPD+ascorbate (B). The data
points are averages of 10 independent experiments. Experimen-
tal conditions as described in [52,73]. A: 10 mM succinate, 10
mM glutamate, 5 mM malate and 2 mM ADP present. The
100% value corresponds to 248 þ 84 nmol O2/min/mg protein at
30‡C. B: 500 WM TMPD, 1 mM ascorbate, 2 mM ADP and
0.2 WM antimycin present. The 100% value corresponds to
336 þ 94 nmol O2/min/mg protein at 30‡C.
Fig. 4. Threshold plot of cytochrome c oxidase in succinate+
glutamate+malate oxidizing skeletal muscle mitochondria. The
experimental data shown in Fig. 3A,B are re-plotted according
to [66,68,73]. COXT ^ threshold of cytochrome c oxidase.
COXRmax ^ reserve capacity of cytochrome c oxidase.
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nmol O2/min/mg protein; glutamate+malate+succi-
nate, 248 þ 84 nmol O2/min/mg protein (at 30‡C, 10
independent preparations). Similar observations were
made for the threshold plot of the adenine nucleotide
translocator in rat liver mitochondria [67]. With the
substrates pyruvate+malate, a high threshold was de-
termined while in the presence of succinate the curve
changed, indicating a much lower threshold (cf. ¢g-
ure 3F in [67]).
These are clear examples that metabolic thresholds
similar to £ux control coe⁄cients are extremely de-
pendent on the detailed experimental condition and
cannot simply be generalized. Nevertheless, the re-
sults with cytochrome c oxidase could explain why
de¢ciencies of this enzyme have a preferential expres-
sion in skeletal muscle [54,70] but not in brain [71].
Moreover, the low thresholds of cytochrome c oxi-
dase under conditions of maximal electron £ow
through respiratory chain are in line with ¢ndings
that mitochondrial DNA mutations at a low degree
of heteroplasmy a¡ect muscle energy metabolism and
cause a pathological phenotype [72,73]. Despite the
fact that £ux coe⁄cients and also metabolic thresh-
old values depend largely on the £ux rate and the
detailed metabolic system studied, they can be used
for quantitative estimation of the metabolic in£uence
of enzyme de¢ciencies. This approach has been ap-
plied for the description of metabolic consequences
of respiratory chain enzyme de¢ciencies in mitochon-
drial myopathies [74].
6. Concluding remarks
The classical concept of ATP-demand control of
energy metabolism in skeletal muscle has to be modi-
¢ed on the basis of applications of metabolic control
analysis showing very clearly multistep control.
However, the amount of control of the individual
steps is to a large extent dependent on the individual
conditions, which include the £ux rate, the availabil-
ity of metabolites, possible di¡usion limitations and
the enzyme composition (which can be altered by
genetic defects). Nevertheless, the concept of multi-
step control within the framework of metabolic con-
trol analysis allows to quantify the individual in£u-
ence of any parameter of a well de¢ned complex
system and is therefore extremely helpful to analyze
the metabolic consequences of enzyme de¢ciencies in
skeletal muscle.
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